Lung cancer: open trials in Greece

68 open trials have a site in Greece. Registry data; only the trial team decides who can take part.

2026-526300-67-00
A Study of Ivonescimab Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC
Trial Treatment · Phase 3 · Summit Therapeutics Inc.
Henry Dunant Hospital Center, Athens · General Hospital of Athens - Alexandra, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · Metropolitan General Hospital Healthcare Facilities Operation And Management Single Member S.A., Cholargos · Olympion General Clinic Patras P.C., Patras · Metropolitan Hospital, Pireas · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki · Athens Medical Center S.A., Thessaloniki
Registry updated 2026-11-06
NCT05920356
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Trial Treatment · Phase 3 · Amgen
University General Hospital of Alexandroupoli, Alexandroupoli · 251 Air Force General Hospital, Athens · Alexandra Hospital, Athens · Athens Medical Center S.A., Maroussi · General University Hospital Of Patras, Patras · Metaxa Cancer Center Hospital Of Piraeus, Pireas · Metropolitan Hospital, Pireas · Athens Medical Center S.A., Thessaloniki · Theageneio Cancer Hospital, Thessaloniki
Registry updated 2026-11-06
NCT06793215
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Trial Treatment · Phase 3 · Hoffmann-La Roche
Errikos Dynan Hospital, Athens · Sotiria General Hospital of Athens, Athens · Alexandras Hospital, Athens · University Hospital of Larissa, Larissa · Ag. Loukas Hospital, Thessaloniki · Interbalkan Medical Center of Thessaloniki, Thessaloniki · Theageneion Anticancer Hospital, Thessaloniki
Registry updated 2026-11-05
NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · Pfizer
Henry Dunant Hospital Center, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · University General Hospital of Heraklion, Heraklion · General University Hospital of Larissa, Larissa · Metropolitan Hospital, Pireas · Athens Medical Center S.A., Thessaloniki · St. Luke's Hospital S.A., Thessaloniki
Registry updated 2026-11-05
NCT07361497
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Laiko General Hospital of Athens, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · Henry Dunant Hospital Center, Athens · General Hospital Of Thessaloniki Papageorgiou, Efkarpia · General University Hospital of Larissa, Larissa · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki
Registry updated 2026-11-05
NCT06119581
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
St Savas Hospital, Athens · Henry Dunant Hospital Center, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · University General Hospital Attikon, Athens · University General Hospital of Heraklion, Heraklion · General University Hospital Of Patras, Patras · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki · Theageneio Cancer Hospital, Thessaloniki · Athens Medical Center S.A., Thessaloniki
Registry updated 2026-11-04
NCT06452277
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 3 · Bayer
Thoracic General Hospital of Athens "I Sotiria", Athens · University General Hospital Attikon, Athens · Alexandra Hospital, Athens · Henry Dunant Hospital Center, Athens · General University Hospital of Larissa, Larissa · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki · Genesis Mikti Idiotiki Kliniki Gynaikas A.E. Maieutiki Gynaikologiki Cheirourgiki, Thessaloniki
Registry updated 2026-11-04
NCT06890598
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Thoracic General Hospital of Athens "I Sotiria", Athens · Errikos Dunant Hospital Center, Athens · Agios Savvas Regional Cancer Hospital, Athens · University General Hospital of Heraklion, Heraklion · University General Hospital of Larissa, Larissa · University Hospital of Patras, Pátrai · European Interbalkan Medical Center, Thessaloniki · Agios Loukas Clinic, Thessaloniki
Registry updated 2026-11-04
NCT06667076
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
Henry Dunant Hospital Center, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · Metaxa Cancer Center Hospital Of Piraeus, Pireas · Athens Medical Center S.A., Thessaloniki · Theageneio Cancer Hospital, Thessaloniki
Registry updated 2026-11-03
NCT07365319
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Henry Dunant Hospital Center, Athens · Metaxa Cancer Center Hospital Of Piraeus, Pireas · Theageneio Cancer Hospital, Thessaloniki · Genesis Idiotiki Geniki Maieftiki Gynaikologiki Kliniki S.A., Thessaloniki · Athens Medical Center S.A., Thessaloniki
Registry updated 2026-11-03
NCT06745908
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy
Trial Treatment · Phase 3 · ImmunityBio, Inc.
Thoracic General Hospital of Athens "I Sotiria", Athens · University General Hospital of Ioannina, Ioannina · General University Hospital Of Patras, Patras · Interbalcan Medical Center, Pylaia · St. Luke's Hospital S.A., Thessaloniki · Genesis Idiotiki Geniki Maieftiki Gynaikologiki Kliniki S.A., Thessaloniki
Registry updated 2026-11-02
NCT07185997
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Trial Treatment · Phase 3 · ArriVent BioPharma, Inc.
University General Hospital Attikon General Hospital Of West Attica H Agia Varvara, Athens · Henry Dunant Hospital Center, Athens · Thoracic General Hospital of Athens I Sotiria, Thessaloniki · Athens Medical Center S.A., European Interbalkan Medical Center, Thessaloniki
Registry updated 2026-11-02
NCT07195695
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Trial Treatment · Phase 3 · Boehringer Ingelheim
Henry Dunant Hospital Center, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári
Registry updated 2026-11-02
NCT07431827
MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Evangelismos S A, Athens · Henry Dunant Hospital Center, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · Athens Medical Center S.A., Maroussi · Metaxa Cancer Center Hospital Of Piraeus, Pireas · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki
Registry updated 2026-11-02
NCT07554339
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
University General Hospital of Alexandroupoli, Alexandroupoli · General Hospital of Athens - Alexandra, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · Athens Medical Center S.A., Maroussi · Metaxa Cancer Center Hospital Of Piraeus, Pireas
Registry updated 2026-11-02
NCT04613596
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Trial Treatment · Phase 2/3 · Mirati Therapeutics Inc.
Thoracic General Hospital of Athens "I Sotiria", Athens · Alexandra Hospital, Athens · Henry Dunant Hospital Center, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · University General Hospital of Heraklion, Heraklion · General Oncological Hospital Of Kifissia Agioi Anargyroi, Kifissia · General University Hospital of Larissa, Larissa · Metropolitan Hospital, Pireas · St. Luke's Hospital S.A., Thessaloniki
Registry updated 2026-10-30
NCT06623422
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Henry Dunant Hospital Center, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · University General Hospital Attikon, Athens · General Hospital Of Thessaloniki Papageorgiou, Efkarpia · University General Hospital of Heraklion, Heraklion · General University Hospital of Larissa, Larissa · General University Hospital Of Patras, Patras · Metropolitan Hospital, Pireas
Registry updated 2026-10-30
NCT07513376
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Henry Dunant Hospital Center, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · Athens Medical Center S.A., Thessaloniki
Registry updated 2026-10-30
NCT04928846
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · AbbVie
Henry Dunant Hospital Center, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · Metropolitan Hospital, Pireas · Athens Medical Center S.A., Thessaloniki
Registry updated 2026-10-29
NCT07472517
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Trial Treatment · Phase 3 · Boehringer Ingelheim
Henry Dunant Hospital Center, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki
Registry updated 2026-10-28
NCT07900581
Analysis of Whole Exome and Transcriptome Sequencing to Identify Prognostic Biomarkers in Patients With Non-Small Cell Lung Cancer (NSCLC)
Research · Hellenic Cooperative Oncology Group
4th Oncology Department, Metropolitan Hospital, Athens · 2nd Oncology Department, Metropolitan Hospital, Athens · Euroclinic Athens, Athens · Alexandra General Hospital, Athens · Henry Dunant Hospital Center, Athens · General Oncology Hospital Agioi Anargyroi, Athens · 401 General Military Hospital of Athens, Athens · HYGEIA Hospital, Athens · Attikon University General Hospital, Athens · MITERA Private Hospital, Athens · Kavala General Hospital, Kavala · General Hospital Agios Andreas, Pátrai · University General Hospital of Patras, Pátrai · Saint Luke's Clinic, Thessaloniki · Euromedica General Clinic, Thessaloniki · Thessaloniki General Hospital "George Papanikolaou", Thessaloniki · Theagenio Anti-Cancer Hospital of Thessaloniki, Thessaloniki
Registry updated 2026-10-28
NCT06875310
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Trial Treatment · Phase 3 · Mirati Therapeutics Inc.
Henry Dunant Hospital Center, Athens · Thoracic General Hospital of Athens "I Sotiria", Athens · General University Hospital of Larissa, Larissa
Registry updated 2026-10-27
NCT06345729
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Thoracic General Hospital of Athens "I Sotiria", Athens · Saint Savvas Oncology Hospital, Athens · General University Hospital of Larissa, Larissa · Athens Medical Center S.A., Maroussi · General University Hospital Of Patras, Patras · Metaxa Cancer Center Hospital Of Piraeus, Pireas · Athens Medical Center S.A., Thessaloniki · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki
Registry updated 2026-10-26
NCT07190248
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Thoracic General Hospital of Athens "I Sotiria", Athens · Henry Dunant Hospital Center, Athens · Laiko General Hospital of Athens, Athens · Metropolitan General Hospital Healthcare Facilities Operation And Management Single Member S.A., Cholargos · General Hospital Of Thessaloniki Papageorgiou, Efkarpia · General Hospital Of Patras Agios Andreas, Patras
Registry updated 2026-10-26
2023-509340-10-00
A phase 3 trial comparing a therapeutic cancer vaccine OSE2101 to chemotherapy docetaxel in patients with metastatic Non-Small Cell Lung Cancer (NSCLC) after immunotherapy failure.
Trial Treatment · Phase 3 · OSE Immunotherapeutics
Thoracic General Hospital of Athens "I Sotiria", Athens · Henry Dunant Hospital Center, Athens · St. Savas Hospita, Athens · General Hospital Of Thessaloniki Papageorgiou, Efkarpia · University General Hospital of Heraklion, Heraklion · General Oncological Hospital Of Kifissia Agioi Anargyroi, Kifissia · General University Hospital of Larissa, Larissa · General University Hospital Of Patras, Patras · Metropolitan Hospital, Pireas · Theageneio Cancer Hospital, Thessaloniki · St. Luke's Hospital S.A., Thessaloniki
Registry updated 2026-10-23

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error